Kaleyra, Inc.: Nasdaq/NYSE listing notice — Kaleyra receives NYSE delisting notice for market cap deficiency; stock to trade with .BC

Kaleyra, Inc.

NYSE notified Kaleyra on April 3, 2023 that 30-day avg market cap ($31.5M) and stockholders' equity ($42.2M) both below $50M threshold.
Company has 45 days to submit a business plan to NYSE to demonstrate ability to regain compliance within 18 months.
NYSE confirmed Kaleyra regained compliance with $1.00 minimum avg closing price rule (previously non-compliant since Nov 2022).
Common stock will continue trading on NYSE under symbol KLR with ".BC" designation during cure period.
Notice does not affect SEC reporting obligations or trigger default under debt agreements.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Kaleyra, Inc. received a nyse deficiency notice notice regarding market value (rules 802.01B).

Exchange: nyse
Notice: deficiency notice
Deficiency: market value
Rules: 802.01B

Exact text from the filing

stockholders’ equity was less than $50 million (the “Market Capitalization Deficiency”). As of March 31, 2023, the 30 trading-day average market capitalization was approximately $31.5 million, and its last reported stockholders’ equity was $42.2 million as of December 31, 2022. In accordance with applicable NYSE procedures, the Company has 45 days from receipt of the

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001193125-23-093185

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.